US FDA approves Otsuka's kidney disease drug

Nov 25 (Reuters) - The U.S. Food and Drug Administration has approved Otsuka’s (4578.T) injectable drug to treat patients with a potentially life-threatening kidney disease, the health regulator’s website showed on Tuesday.